BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aebi-popp K, Duppenthaler A, Rauch A, De Gottardi A, Kahlert C. Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. Journal of Virus Eradication 2016;2:52-4. [DOI: 10.1016/s2055-6640(20)30685-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Yakimova AV, Mukhamedshina VR, Kucherenko SG. Viral hepatitis C during pregnancy: prevalence, impact on perinatal outcomes, patient management tactics (literature review). Consilium Medicum 2022;24:477-480. [DOI: 10.26442/20751753.2022.7.201799] [Reference Citation Analysis]
2 Passos MRL, Junior JE, Kreitchmann R, Miranda AE. Congenital Infection 1 (Syphilis, AIDS, and Viral Hepatitis). Perinatology 2022. [DOI: 10.1007/978-3-030-83434-0_44] [Reference Citation Analysis]
3 Ranes de Menezes Filho H, Maia LG, Machado SM, Ramos da Silva I, de Almeida-neto C, Sabino EC, Witkin SS, Mendes-corrêa MC. Knowledge of Hepatitis C virus vertical transmission and subsequent pregnancy outcome in virus-positive female blood donors. The Brazilian Journal of Infectious Diseases 2022;26:102334. [DOI: 10.1016/j.bjid.2022.102334] [Reference Citation Analysis]
4 Ades AE, Gordon F, Scott K, Collins J, Thorne C, Pembrey L, Chappell E, Mariné-barjoan E, Butler K, Indolfi G, Gibb DM, Judd A. Overall vertical transmission of HCV, transmission net of clearance, and timing of transmission.. [DOI: 10.1101/2021.09.28.21264075] [Reference Citation Analysis]
5 Freire JDO, Schuch JB, Miranda MFD, Roglio VS, Tanajura H, Victa AGLBD, Diemen LV. Prevalence of HIV, Syphilis, Hepatitis B and C in pregnant women at a maternity hospital in Salvador. Rev Bras Saude Mater Infant 2021;21:945-53. [DOI: 10.1590/1806-93042021000300012] [Reference Citation Analysis]
6 Kushner T, Reau N. Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy. J Hepatol 2021;74:734-41. [PMID: 33248169 DOI: 10.1016/j.jhep.2020.11.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Leung DH, Squires JE, Jhaveri R, Kerkar N, Lin CH, Mohan P, Murray KF, Gonzalez-Peralta RP, Roberts EA, Sundaram SS. Hepatitis C in 2020: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr 2020;71:407-17. [PMID: 32826718 DOI: 10.1097/MPG.0000000000002814] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
8 Freriksen JJM, van Seyen M, Judd A, Gibb DM, Collins IJ, Greupink R, Russel FGM, Drenth JPH, Colbers A, Burger DM. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child. Aliment Pharmacol Ther 2019;50:738-50. [PMID: 31448450 DOI: 10.1111/apt.15476] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
9 Pinho JRR, de Mello Malta F, Gomes-gouvêa MS. Hepatitis B, C, and Delta—Updates in Screening and Infection Prevention Opportunities for Eradication. Curr Treat Options Infect Dis 2017;9:18-33. [DOI: 10.1007/s40506-017-0105-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]